About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
25 10, 2024

Cardano (ADA) October End Price Prediction

By |2024-10-25T03:11:04+03:00October 25, 2024|Crypto News, News|0 Comments

Cardano (ADA) is trading around the $0.34 level on Thursday, down nearly 4% in the day’s trade. The leading altcoin has had a rough year as its price massively dwindled in the last 10 months. It started the year at $0.60 and slumped close to 45% year-to-date. The development is testing investors’ patience as several other obscure tokens outperform the top 10 cryptocurrencies in the market.

Also Read: Cryptocurrency: Top 3 Coins That May Hit All Time Highs In November

Cardano (ADA) October End Price Prediction
Source: Coingecko

So, will Cardano dust itself from the fall and scale up in the charts by the end of October 2024? This article will highlight how high or low ADA could reach in the charts next week.

Also Read: Morgan Stanley (MS) Stock Nears All-Time High: Can It Go Much Higher?

Cardano Price Prediction: Time to Buy ADA?

Cardano ADA
Source – R7

Leading on-chain metrics and price prediction firm Changelly has painted a sluggish forecast for Cardano’s native token ADA. According to the price prediction, the maximum ADA could rise by the end of October to $0.36 if the altcoin picks up steam and heads north in the next seven days. If it fails to rally, the price could remain at $0.34 with little to no changes.

Also Read: Russia’s Push: Precious Metals to Lead De-Dollarization Effort

Source: Changelly

Cardano’s ADA is among the least-performing cryptocurrencies in the market this year. Despite Bitcoin reaching the $67,000 mark in the indices, it has failed to attract buying pressure. The Cardano blockchain has also launched several upgrades, but the developments barely positively affected its price.

Also Read: Multipolar Currency Era Looms As Russia, China Challenge The US Dollar

This puts the cryptocurrency on the ‘no buy’ list as earning profits becomes challenging. Apart from ADA, many other cryptocurrencies are primed to deliver decent returns in November. Read here to learn how high Shiba Inu (SHIB) could go in the charts next month.

In addition, Binance Coin (BNB) is also expected to surge in the indices this Halloween. Read here to know how high BNB can spike in the charts. While other tokens are primed to print profits, it is advised to stay away from Cardano’s ADA currently.

Source link

25 10, 2024

Natural Gas Price Forecast: Targets 50% Retracement Amid Growing Bullish Momentum

By |2024-10-25T02:52:13+03:00October 25, 2024|Forex News, News|0 Comments


Next Target is 2.52

The 38.2% Fibonacci retracement at 2.52 was easily exceeded today putting natural gas in line to test resistance around 50% retracement at 2.615. That price area is strengthened by the 20-Day MA (purple), which is currently showing the same price level. The 20-Day line reflected support of the prior uptrend following the September 3 upside breakout of the line. It failed to maintain support once the price of natural gas closed below it on October 11. Now, it presents a potential area of resistance. Plus, once the 50-Day MA is cleared, as occurred today, the next moving average in the sequence becomes an upside target.

61.8% Fibonacci Retracement at 2.71 Looks Likely

Nonetheless, since this week’s swing low was higher than the previous swing low, the current advance has the potential to eventually exceed the 50% retracement and target the 61.8% Fibonacci retracement at 2.71. An unfilled gap begins at 2.66 and goes to 2.72, filling right around the Fibonacci level. The top down trendline was successfully tested as resistance during the formation of the recent 3.02 swing high. That was essentially the third touch of the top trendline following the beginning of the line starting from the October 2023 peak. This identifies the line as solid resistance and indicates the potential for a sharp rally if it is exceeded to the upside.

Trendlines Mark Near-term Boundaries

Current price action is proceeding between two trendlines, resistance at the top and support at a new internal rising trendline connecting the August swing low with this week’s swing low. The intersection of the lines can tell us something about timing as they cross January 3, 2025. A vertical dotted line has been placed at the intersection. One of the two lines will be broken before then and that should tell us something about the strength or weakness of natural gas.

For a look at all of today’s economic events, check out our economic calendar.



Source link

25 10, 2024

CarnoSyn® Brands Announces New U.S. Distribution Agreement

By |2024-10-25T01:36:32+03:00October 25, 2024|Dietary Supplements News, News|0 Comments


CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), are pleased to announce a new distribution partnership with B&D Nutritional Ingredients, Inc., a renowned raw material distributor in the dietary supplement industry since 1993. This strategic partnership took effect on October 1st, 2024.

Under the terms of the agreement, B&D will distribute NAI’s newly introduced carnosine booster, TriBsyn™, to the U.S.-based nutritional dietary supplement, functional food, and beverage market segments. Carnosine, which is naturally produced in the body through the synthesizing of beta-alanine and histidine, is a powerful antioxidant that has been shown to provide health benefits for muscle, brain, heart, bone, and overall systemic health. NAI’s new TriBsyn™ product is a patent-pending ingredient that utilizes proprietary technology to increase beta-alanine bioavailability and absorption, while effectively eliminating the common paresthesia sensation associated with efficacious dosages of beta-alanine. TriBsyn™ provides the opportunity to reach untapped consumers from older adults to vegetarians, vegans, and others looking to boost their carnosine levels.

“This strategic partnership between NAI and B&D is a testament to our longstanding business relationship,” said Mark LeDoux, CEO and Chairman of the Board at NAI. “B&D’s reputation and commitment to their customers is unwavering. This distribution agreement will help drive the awareness and growth of the TriBsyn™ innovation launched in August 2024. We are excited to broaden our distribution efforts with B&D and to share our groundbreaking new ingredient with the industry.”

B&D is a leading distributor specializing in the dietary supplement, functional food and beverage, personal care, pet health, and craft brewery industries. TriBsyn™ represents the latest innovative ingredient added to B&D’s specialty ingredient portfolio for distribution. Their well-stocked warehouse complements just-in-time inventory needs, and a deep understanding of the industry makes B&D a first-class partner.

“B&D is honored to be NAI’s partner to promote TriBsyn™,” stated Bill Van Dyke, B&D President. “TriBsyn™ fits B&Ds’ portfolio and model extremely well by being a clinically supported and unique dietary ingredient. We believe TriBsyn™ will be an excellent ingredient for anti-aging, cognitive function, and support of physical activity.”

About B&D Nutritional Ingredients, Inc.
Founded in 1993 and based in Carlsbad, California, B&D Nutritional Ingredients, Inc. is a national leader in the sales, distribution, and marketing of high-quality dietary ingredients and flavors to the dietary supplement, functional food and beverage, personal care, pet health, and craft brewery industries. B&D has a portfolio of premium ingredients from leading manufacturers supporting a wide array of health benefits that today’s consumers are looking for. B&D is active in several industry organizations representing the dietary supplement, personal care, and pet health industries. Memberships include, Natural Products Association, Consumer Healthcare Products Association, Association of American Feed Control Officials, National Animal Supplement Council. For more information, visit www.bdnutritional.com.

About CarnoSyn® Brands:
CarnoSyn® Brands feature three clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine powder, SR CarnoSyn® sustained release beta-alanine tablets, and TriBsyn™ powder. In 2019, CarnoSyn® beta-alanine successfully obtained NDI status from the FDA and received Self-Affirmed GRAS (Generally Recognized as Safe) status. SR CarnoSyn®, an advanced delivery form of CarnoSyn®, received GRAS affirmation in 2017. The new “paresthesia-free” TriBsyn™ powder allows NAI to broaden their product offerings within the dietary supplement category, including medical and other fortified food products. To learn more about SR CarnoSyn® in active nutrition and wellness, visit www.srcarnosyn.com. For more information about the latest innovation, TriBsyn™, visit www.tribsyn.com.

About NAI:
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to clients including scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. For more information about NAI, please visit www.nai-online.com.

            



Source link

25 10, 2024

Arabica coffee tends to recover, Robusta continues to fluctuate

By |2024-10-25T00:50:52+03:00October 25, 2024|Forex News, News|0 Comments


Experts predict that on October 25, 10, coffee prices in the domestic market are expected to continue to increase in many localities, especially in the Central Highlands.

The strong USD has pushed down the prices of gold and crude oil. However, coffee has recovered after falling too much in the previous days. The market has seen resistance as new crop supplies from Vietnam have not yet joined the transaction.

Dealers said foreign demand for Vietnamese coffee is declining, as many countries have secured coffee supplies from other sources, especially as the EU’s deforestation regulation is expected to take effect by the end of 2024, a delay from the original plan.

Speculators are also reducing net long positions ahead of the harvest in the top robusta producing nation. world, which is expected to ramp up sales next month. The European Union’s (EU) delay in implementing its anti-deforestation law, the EUDR, has reduced the urgency for new deals, further dampening the market.

Coffee price quote October 25, 10: Arabica coffee tends to recover, Robusta continues to fluctuate

According to experts, in the world market, Arabica coffee prices are likely to recover strongly, while Robusta tends to continue to fluctuate.

Recorded in the trading session on October 24, 10, domestic coffee prices today decreased sharply by 2024 – 1.600 VND/kg, ranging from 1.900 – 109.400 VND/kg. Currently, the average purchase price in the Central Highlands provinces is 109.700 VND/kg, the highest purchase price in the province Dak Nong 109.700 VND/kg.

Specifically, the coffee purchase price in the province Gia Lai (Chu Prong) is 109.600 VND, down 1.800 VND/kg compared to yesterday, in Pleiku and La Grai the same price is 109.500 VND/kg; In the province Kon Tum at the price of 109.600 VND/kg, down 1.800 VND/kg compared to yesterday; In Dak Nong province, coffee was purchased at the highest price of 109.700 VND/kg, down 1.900 VND/kg compared to yesterday.

Price of green coffee beans (coffee beans, fresh coffee beans) in the province Lam Dong In districts such as Bao Loc, Di Linh, Lam Ha, coffee is purchased at 109.400 VND/kg, down 1.600 VND/kg compared to yesterday.

Coffee prices today (April 24) in the province Dak LakIn Cu M’gar district, coffee was purchased at about 109.600 VND/kg, down 1.800 VND/kg, while in Ea H’leo district and Buon Ho town, it was purchased at the same price of 109.700 VND/kg.

Updated world coffee prices at 20:00 p.m. on September 24, 10, Vietnam time on the London exchange, the price of Robusta coffee futures contract for September 2024 delivery on the London exchange was at 11 USD/ton, down 2024 USD compared to the beginning of the trading session.

Coffee price forecast on June 25, 10:
Coffee prices today, July 24, 10: Robusta coffee prices on the London floor. (Photo: Screenshot from giacaphe.com

Delivery term in November 1 is 2025 USD/ton, down 4.425 USD; Delivery term in January 78 is 3 USD/ton, down 2025 USD and delivery term in March 4.335 is 70 USD/ton, down 5 USD.

Coffee price forecast on June 25, 10:
Arabica coffee prices on the New York floor on October 24, 10. (Photo: Screenshot of giacaphe.com)

In particular, the price of Arabica coffee on the New York floor today at 20:00 p.m. on September 24, 10 decreased in all terms, fluctuating at 2024 – 242.55 cents/lb.

Specifically, the delivery term in December 12 is 2024 cents/lb; down 247.65 cents/lb compared to the beginning of the session. March 4.70 delivery is 3 cents/lb, down 2025 cents/lb; Delivery period in May 246.50 is 4.55 cents/lb, down 5 cents/lb and delivery period in July 2025 is 245.00 cents/lb, down 4.55 cents/lb.

Coffee price forecast on June 25, 10:
Brazilian Arabica coffee price on October 24, 10. (Photo: Screenshot of giacaphe.com)

The price of Brazilian Arabica coffee today at 21:00 p.m. on October 24, 10 increased and decreased in opposite directions. Specifically, the delivery period for December 2024 is 12 USD/ton, down 2024%; the delivery period for March 301.65 is 0.66 USD/ton, down 3%; the delivery period for May 2025 is 302.15 USD/ton, up 0.80% and the delivery period for July 5 is 2025 USD/ton, up 305.90%.

Robusta coffee traded on ICE Futures Europe (London floor) opens at 16:00 and closes at 00:30 (the next day), Vietnam time.

Arabica coffee on the ICE Futures US floor (New York floor) opens at 16:15 p.m. and closes at 01:30 a.m. (the next day), Vietnam time.

The 2023-2024 crop year ended with a supply-demand balance tilted towards a surplus of 1 million bags. However, the 2024-2025 coffee output is forecast to be heavily impacted by extreme weather factors. Therefore, coffee prices in the third quarter are expected to remain high, double that of the same period last year.

Industry insiders believe that coffee prices in the fourth quarter may be adjusted down due to additional supply from major coffee growing countries, including Vietnam.

*Information is for reference only, prices may vary depending on region and locality

Sources: https://congthuong.vn/du-bao-gia-ca-phe-ngay-25102024-ca-phe-arabica-co-chieu-huong-phuc-hoi-robusta-tiep-tuc-bien-dong-354536.html



Source link

24 10, 2024

Green Tea Fragrances Are So Back—Try These Fresh Scents

By |2024-10-24T23:35:19+03:00October 24, 2024|Dietary Supplements News, News|0 Comments


With a limited number of bottles, 4,205 to be exact, this splurge is a collector’s item for the ages. The bottle is almost too beautiful to use and can act as decor for many years to come, but if you do spritz the spray, you’ll be immersed in cherry blossoms, green tea accord, bergamot, lilac, jasmine and white musk. The scent beams with the freshness of a spring, sunkissed morning.





Source link

24 10, 2024

EUR/USD Outlook: Eurozone Business Slump Dampens Outlook

By |2024-10-24T23:11:23+03:00October 24, 2024|Forex News, News|0 Comments

  • Data on Thursday revealed that Eurozone business activity remained weak in October. 
  • Markets are fully pricing a 25-bps ECB rate cut in December.
  • US PMI numbers will show the state of business activity.

The EUR/USD outlook leans south despite a short rebound as data revealed poor business activity in the Eurozone. However, the pair edged higher as the dollar eased amid uncertainty regarding the upcoming US presidential election. 

–Are you interested to learn more about Australian forex brokers? Check our detailed guide-

Data on Thursday revealed that Eurozone business activity remained weak in October. The composite PMI came in at 49.7 compared to forecasts of 49.8. Figures below the 50 mark indicate contraction and weak economic demand. Consequently, market participants have increased bets for another European Central Bank rate cut in December. Markets are fully pricing a 25-bps rate cut in December.

However, ECB’s Christine Lagarde emphasized caution on Wednesday when deciding policy. However, other policymakers have expressed more dovish remarks. Nevertheless, the euro recovered Thursday while the dollar eased from recent peaks ahead of the US presidential election. 

For weeks, the greenback has rallied as traders bet on a Trump win and higher inflation. However, a recent Reuters poll showed that Kamala Harris was in the lead, indicating a tight race. The uncertainty has caused some investors to pause and lock in profits before the election. 

Meanwhile, market participants await more hints on the future of Fed policy. US unemployment claims will show whether demand remains high in the labor market, which could lower bets for a November rate cut. Meanwhile, PMI numbers will show the state of business activity.

The outlook for Fed policy has shifted to a more gradual one. Moreover, policymakers have assumed a more hawkish tone. Consequently, markets are placing a 29% chance that the central bank will cut rates only once more this year.

EUR/USD key events today

  • Unemployment Claims
  • Flash Manufacturing PMI
  • Flash Services PMI

EUR/USD technical outlook: Bears leading below the 30-SMA

EUR/USD Outlook: Eurozone Business Slump Dampens Outlook
EUR/USD 4-hour chart

On the technical side, the EUR/USD price has rebounded to retest the 1.0801 key level. However, the downtrend remains intact since the price recently made a lower low. Moreover, it trades below the 30-SMA, with the RSI below 50, in bearish territory. 

If you are interested in guaranteed stop-loss forex brokers, check our detailed guide-

Therefore, even if the uptrend continues, it might pause at the 30-SMA resistance. Here, the price will likely bounce lower to continue the downtrend beyond the 1.0750 level. However, if the price breaks above the SMA, the trend might reverse to the upside.

Looking to trade forex now? Invest at eToro!

68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Source link

24 10, 2024

Medicare and Obesity – HealthyWomen

By |2024-10-24T23:03:23+03:00October 24, 2024|Fitness News, News|0 Comments

For millions of people living with obesity, the class of weight-loss medications known as GLP-1 agonists have been game-changers (think Wegovy and Zepbound). Studies show that people on these medications can lose more weight than they can with just lifestyle changes alone.

But for one group of Americans — people on Medicare — at least some of these drugs have been off-limits because Medicare is not allowed to cover medications prescribed for the sole purpose of weight loss. With ample evidence that obesity itself increases numerous health risks and new indications that these drugs lower risks of heart disease and stroke, those limits may be changing.

A bipartisan bill, the Treat and Reduce Obesity Act (TROA), moving through Congress would allow Medicare to cover weight-loss medications for the first time.

Experts argue it’s about time.

“The passage of the Treat and Reduce Obesity Act (TROA) is crucial for protecting women’s access to obesity care as they transition to Medicare,” said Fatima Cody Stanford, M.D., M.P.H., M.P.A., associate professor of medicine and pediatrics at Harvard Medical School and obesity medicine physician-scientist in the Massachusetts General Hospital Weight Center.

Stanford explains that TROA improves comprehensive coverage while improving equitable access to care.

“The TROA aims to expand Medicare coverage to include a wider range of obesity treatments, including FDA-approved medications and intensive behavioral therapy. This ensures that women can continue their established treatment regimens without interruption,” she said. “The TROA addresses disparities in healthcare access, ensuring that all women, regardless of their financial situation, can receive the necessary treatments to manage their obesity effectively.”

The costs of obesity

For 31 million women over age 65 (and another 4 million younger women who qualify for Medicare because of long-term disabilities), Medicare’s lack of obesity care coverage creates risks. Approximately 10,000 Americans turn 65 every day, more than half of whom are women. With obesity rates reaching 43% in people over age 60, losing access to obesity treatments can be especially detrimental.

“When women transition from private insurance to Medicare at the age of 65, they often face a significant loss in coverage for obesity treatments,” Stanford said. “When women who have been receiving consistent obesity treatment, including medications, behavioral therapy and nutritional counseling, experience an abrupt halt in their care, this can lead to weight regain and worsening of obesity-related conditions.”

Experts recognize obesity as a chronic medical condition. According to the CDC, 2 out of every 5 American adults are living with obesity. Almost 6 out of 10 of them also have high blood pressure, which raises their risks for heart disease. Nearly 1 out of 4 also have diabetes. Obesity is also known to increase the risks of certain cancers, pregnancy and fertility problems, and mental health issues, among other conditions.

“Obesity is a chronic disease that requires ongoing management,” said Alicia Shelly, M.D., obesity medicine physician. “Without Medicare coverage for obesity treatment, women are at increased risk for serious health issues like heart disease, diabetes and cancer. Long-term support is essential to help prevent these life-threatening conditions.”

Obesity is also a serious economic issue. People with obesity have nearly $2,000 more in annual medical costs than people without obesity. Overall, those costs add up to nearly $173 billion in extra medical costs each year in the U.S.

And that’s just direct medical costs associated with obesity. Add to that lost productivity that results when employees miss work, are less productive at work due to obesity complications, or prematurely die or leave the workforce due to disability. The CDC estimates that obesity-related missed work alone costs between $3.38 and $6.38 billion each year.

TROA is one way to reduce these costs.

“By providing coverage for obesity treatments, the TROA supports preventive health measures, reducing the incidence of obesity-related diseases and lowering long-term healthcare costs,” Stanford said.

In women’s own voices

In a HealthyWomen survey of 1,000 women ages 35 to 64, nearly one-quarter reported having been diagnosed with obesity, and 79% said they were trying to lose weight or lower their BMI. Another 8% of respondents said they are caregiving for someone living with obesity.

Nearly two-thirds of women living with obesity reported dieting or considering doing so, and one in five said they’re taking or considering taking an anti-obesity medication (AOM).

The survey results show that 8 out of 10 women who consult a nutritionist said their insurance covers all or part of those costs, but only 6 out of 10 said the same about insurance coverage for AOMs.

Women living with obesity said that achieving their desired weight would have the biggest positive impact on their physical and mental health, self-confidence, and daily activities. But 11% of survey respondents who reported that they will turn 65 in the next six months (or are caregiving for someone who will) will not have access to AOMs under the current rules. Seven percent of women said they have a plan that will no longer cover their AOM next year or that they’re caring for someone in that situation.

The survey also revealed racial and ethnic health disparities. Nearly one-third of respondents said they have been diagnosed with obesity or would be if they went to a healthcare provider (HCP) who would assess their weight. And Black respondents were twice as likely than Hispanic/Latina respondents to categorize themselves this way.

Insurance status also showed important differences. People on Medicaid, the public insurance program for Americans with lower incomes, were more likely to say they had been diagnosed with obesity (31%) compared with 20% of those with job-based insurance and 17% with other private coverage. Among survey respondents with Medicare coverage, 13% said they care for someone with obesity and 26% are living with obesity.

Fighting for coverage

“The sudden lack of support and resources can have a detrimental effect on mental health, leading to feelings of helplessness, frustration and depression,” Stanford said. “This can further exacerbate the challenges associated with managing obesity.”

Stanford recommends that women transitioning onto Medicare be proactive about their care, such as reviewing various Medicare plan options to find the most comprehensive obesity coverage available and/or adding supplemental coverage (known as Medigap). She also recommends consulting HCPs to plan for the transition in advance and get their help navigating coverage or finding alternative treatments.

“I recommend developing a plan that outlines the available and affordable obesity treatments,” Shelly said. “Currently, Medicare does not cover weight loss medications, so it’s important to prioritize optimizing your nutrition and physical activity to support weight maintenance.”

More broadly, anyone who is or may someday be covered by Medicare can use their voice to advocate for coverage. Write letters to elected officials, call or visit their offices, or even request meetings to express support for TROA.

“Stay informed about legislative changes like the Treat and Reduce Obesity Act and advocate for their passage,” Stanford said. “Engaging with patient advocacy groups can amplify your voice and help drive policy changes.”

This educational resource was created with support from NovoNordisk, a HealthyWomen Corporate Advisory Council member.

From Your Site Articles

Related Articles Around the Web



Source link

24 10, 2024

CryptoChronic Receives Grant from SKALE to Build Top Gaming DApp on its Chain

By |2024-10-24T22:55:47+03:00October 24, 2024|News, NFT News|0 Comments


Sheung Wan (Hong Kong) , Oct. 24, 2024 (GLOBE NEWSWIRE) — Today, Chronic Games Limited is thrilled to announce that it has been awarded a grant by SKALE Labs, one of the fastest and most cost-effective blockchains in the world, in order to develop its game, CryptoChronic, on their network.

The benefits will extend to all CryptoChronic’s growing ecosystem and will be felt in multiple ways. Not only following the imminent launch on SKALE’s chain, thanks to its technological superiority, gamers will enjoy a completely frictionless experience, 100% free of gas fees. But also, they will benefit from generous airdrops, prizes, and rewards for being engaged members of the community.

SKALE, in fact, operates an ecosystem incentive program to accelerate the adoption of high-quality applications and projects on its network. Its grants are awarded to hand-picked projects, also within the rapidly growing blockchain gaming sector, including play-to-earn (P2E) games and the Metaverse. They aim to exponentially increase the reach and engagement of the awarded gaming projects among the over 34 million active wallets in its network, and beyond.

Chronic Games Limited, based in Hong Kong, is the studio behind CryptoChronic. Dedicated to bringing the fun back to crypto and NFTs, CryptoChronic has developed the first free-to-earn cannabis-themed gaming Metaverse, known as the “Cannaverse.” The game reimagines Pokémon as blockchain-based, virtual pet marijuana strain collectables-Chronics-that players can breed, grow, and battle in multiplayer smoke-offs with friends. With a focus on ultra-fast, seamless, and 100% free blockchain operations, and zero gas fees on the SKALE network, CryptoChronic ensures that gamers can concentrate solely on having fun.

SKALE is a blockchain network that offers limitless scalability, fast performance, and zero gas fees. It enables the quick deployment of interoperable EVM-compatible chains while maintaining security and decentralisation. SKALE is fully decentralised, open-source, and community-owned, with native integration with Ethereum for enhanced security and shared revenue. The network’s capacity increases as new nodes join, supporting limitless scalability. SKALE’s multichain structure provides shared security without shared performance, with each node running 8 chains, rotated to prevent collusion. Using Proof of Stake and efficient containerisation, SKALE optimises resource allocation.

Get the latest news


delivered to your inbox

Sign up for The Manila Times newsletters

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

Marco Prinzi, CEO of Chronic Games, declares, “We feel highly confident in launching our game on the SKALE chain. We aim to bring the fun back to crypto and NFTs, and to do so, we envision providing a completely seamless and frictionless experience for our gamers, ideally making them unaware they are even on-chain. We strive to enable blockchain operations that are ultra-fast, seamless, and 100% free. With zero gas fees on the SKALE network and low barriers to entry, we know our users can focus solely on enjoying our game. We are excited to embark on this adventure together, relying on SKALE’s exceptional technological value.”

This grant represents a significant milestone for Chronic Games Limited and its mission to revolutionise blockchain gaming with CryptoChronic. By leveraging SKALE’s advanced blockchain technology, Chronic Games is poised to deliver an unparalleled gaming experience in the Cannaverse, setting new standards for play-to-earn gaming and NFT integration. With the support of SKALE Labs, Chronic Games is ready to bring a unique and engaging cannabis-themed Metaverse to a global audience, making blockchain gaming more accessible and enjoyable for everyone.

About Chronic Games Limited

Chronic Games Limited is a Hong Kong-based gaming studio dedicated to creating innovative and engaging blockchain-based games. Their flagship project, CryptoChronic, is set to revolutionise the gaming Metaverse with its unique cannabis-themed gameplay and free-to-earn model.

About SKALE

SKALE is a highly scalable, decentralised, and community-owned blockchain network designed to enhance the performance of decentralised applications (DApps). With its zero gas fees, seamless integration with Ethereum, and efficient resource allocation, SKALE provides a robust platform for developers to create and deploy their blockchain projects.

CONTACT: Gengen2023$ Prinzi

Chronic Games Ltd c/o LGP1 Sarl

marco (at) cryptochronic.com

SKALE Labs:

Alex Jivov

alexjivov (at) skalelabs.com



Source link

24 10, 2024

USA EIA Slashes WTI Oil Price Forecast

By |2024-10-24T22:49:57+03:00October 24, 2024|Forex News, News|0 Comments


In its latest short term energy outlook (STEO), which was released earlier this month, the U.S. Energy Information Administration (EIA) cut its West Texas Intermediate (WTI) oil price forecast for both 2024 and 2025.

According to that STEO, the EIA now sees the WTI spot price averaging $76.91 per barrel this year and $73.13 per barrel in 2025. The EIA’s previous STEO, which was released in September, projected that the WTI spot price would average $78.80 per barrel in 2024 and $79.63 per barrel in 2025. Both STEOs put the 2023 WTI spot price average at $77.58 per barrel.

In its latest STEO, the EIA forecast that the WTI spot price would come in at $71.97 per barrel in the fourth quarter of this year, $73.67 per barrel in the first quarter of 2025, $74.50 per barrel in the second quarter, $73.17 per barrel in the third quarter, and $71.22 per barrel in the fourth quarter.

The EIA’s September STEO projected that the WTI spot price would average $77.64 per barrel in the fourth quarter of this year, $79.02 per barrel in the first quarter of 2025, $80.50 per barrel across the second and third quarters of next year, and $78.50 per barrel in the fourth quarter of 2025.

A report sent to Rigzone by Standard Chartered Bank Head of Commodities Research Paul Horsnell late Tuesday revealed that the company is projecting that the NYMEX WTI basis nearby future crude oil price will average $84 per barrel in the fourth quarter of this year, $86 per barrel in the first quarter of 2025, $89 per barrel in the second quarter, $92 per barrel in the third quarter, and $90 per barrel in the fourth quarter.

A research note sent to Rigzone by the JPM Commodities Research team last week showed that J.P. Morgan expects the WTI crude price to average $76 per barrel in the fourth quarter, $78 per barrel in the first quarter of next year, $73 per barrel in the second quarter, $69 per barrel in the third quarter, and $65 per barrel in the fourth quarter.

Executives from oil and gas firms revealed where they expect the WTI crude oil price to be at various points in the future as part of the third quarter Dallas Fed Energy Survey.

The average response executives from 134 oil and gas firms gave when asked what they expect the WTI crude oil price to be at the end of 2024 was $72.66 per barrel, the survey showed. When asked where they expect WTI prices to be in six months, one year, two years, and five years, executives from 119 oil and gas firms gave a mean response of $73 per barrel for the six month mark, $76 per barrel for the year mark, $81 per barrel for the two year mark, and $87 per barrel for the five year mark, the survey outlined.

In a technical analysis of WTI prices sent to Rigzone on Wednesday, Rania Gule, a senior market analyst at XS.com, said, “from a technical perspective, crude oil prices are facing increasing pressures as markets shake off the impacts of the conflict in the Middle East and supply appears to be abundant”.

“To regain momentum, the price needs to surpass the pivotal level at $71.50 with a daily close, which would provide an opportunity to test the level of $75.13, a significant hurdle,” Gule added.

“On the downside, the support level at $67.12 should be monitored; if it is breached, the market could decline to the lowest level of 2024 at $64.75, followed by $64.38,” Gule warned.

In the analysis, Gule stated that, currently, the oil market is undergoing a sideways consolidation phase between $78.00 and $64.00, with the overall outlook leaning towards a neutral to bearish sentiment.

“Momentum indicators suggest a near-term corrective upward move that could reach $75.00 and $78.00 in the medium term, although the price remains below the 200-day simple moving average at $75.37,” Gule added.

To contact the author, email andreas.exarheas@rigzone.com





Source link

24 10, 2024

Trends, innovation, insights in the new era of healthspan

By |2024-10-24T21:34:17+03:00October 24, 2024|Dietary Supplements News, News|0 Comments


Consumers’ thoughts about aging are evolving. It’s no longer merely about more years; they want more healthy years. Understanding this shift can help supplement brands leverage growing product category opportunities as consumer supplement preferences evolve to embrace a vibrant healthspan beyond one-dimensional lifespan.

When it comes to what supplement users worry most about when it comes to aging and improving healthspan, recent sales data show they are spending to act on those concerns. In fact, according to the NBJ 2024 Longevity Report, projected sales of healthy aging supplements will cross the billion-dollar threshold, reaching $1.04 billion in sales on 7.7% growth in 2026.

Join Fran Schoenwetter, with SupplySide and New Hope Network, and Scott Dicker, marketing insights director at SPINS, as they discuss key condition-specific and product innovation trends driving the greatest potential, and how to meet diverse needs within the multitude of categories fueling healthspan product opportunities.

Register today!

Speakers:

Fran Schoenwetter
Director of content marketing, SupplySide, Informa Health & Nutrition

Scott Dicker
Market insights director, SPINS





Source link

Go to Top